PhaseBio Highlights Real-World Healthcare Cost and Bleeding Cost Data
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, recently highlighted a presentation of healthcare …
PhaseBio Highlights Real-World Healthcare Cost and Bleeding Cost Data Read More